US 9885047
Modulation of TMPRSS6 expression
granted A61KA61K31/713A61K45/06
Quick answer
US patent 9885047 (Modulation of TMPRSS6 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/713, A61K45/06